ÌÇÐÄÊÓÆµ

Murugesan Palaniappan

Palaniappan

Murugesan Palaniappan

Assistant Professor

Positions

Assistant Professor
Pathology & Immunology
Center for Drug Discovery
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas, United States
Group Leader
DNA encoded chemical library screening
Center for Drug Discovery
ÌÇÐÄÊÓÆµ of Medicine
Member
Dan L Duncan Comprehensive Cancer Center

Education

PhD from University of Madras
Chennai, India
Postdoctoral Training at University of Michigan
Ann Arbor, Michigan, United States

Professional Interests

  • Breast cancer
  • DNA encoded chemical library screening
  • Drug Discovery and Development

Websites

Selected Publications

  • Devakrishnan AK, Madasu C, Wang Y, Modukuri R, Bohren KM, MacKenzie KR, Young DW, Fuqua SAW, Matzuk MM and Palaniappan M. " " npj Breast Cancer. 2025 Nov 12; 125 (11) : 1-15.
  • Palaniappan M and Bohren KM.. " " J Steroid Biochem Mol Biol.. 2025 Jul ;
    Pubmed PMID: .
  • Palaniappan M. " " Biomedicines. 2024 Dec ; 12 (Estrogen for the Treatment and Prevention of Breast Cancer) : 1-17.
  • Palaniappan M*, Nguyen L, Grimm SL Xi Y, Xia Z, Li W, Coarfa C. " " PloS One. 2019 ;
    Pubmed PMID: .

Memberships

The Endocrine Society
American Association for Cancer Research (AACR)
Active Member

Funding

Development of Next-Generation Estrogen Receptor Mutant Inhibitors for Endocrine Resistant Metastatic Breast Cancer
#RP220524
$769,179.00   (03/01/2022 - 02/28/2025)
Grant funding from CPRIT
Development of a Precision Drug to target Y537S Mutant Estrogen Receptor in Metastatic Breast Cancer
#R03CA259664
$160,000.00   (12/13/2021 - 11/30/2023)
Grant funding from NIH/NCI
Developing Allosteric Small-Molecule Inhibitors of CDK6/Cyclin D to Overcome Resistance in Breast Cancer
#DBG-25-1434888-01-CCB
$297,000.00   (09/01/2025 - 08/31/2027)
Grant funding from American Cancer Society
Breast SPORE Career Enhancement Program Award
(08/01/2022 - 07/31/2023)
Grant funding from NIH/NCI

Skills

SCIENTIST

to edit your profile